Genmab (NASDAQ:GMAB) 주식

Genmab

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Coinbase Photo by Useacoin on Shutterstock

Equities

Large Cap

News

Movers

Trading Ideas

AAPL

ADBE

COIN

EXPE

GMAB

HOOD

IBKR

SAIL

이들 대형 주식은 지난주에 최악의 성과를 보였다. 이 주식이 당신의 포트폴리오에 있나요? 1. 테라다인(NASDAQ:TER)의 주가가 20.08% 하락했다. 이 회사는 포토닉 IC 테스트 회사인 퀀티파이 포토닉스(Quantifi Photonics)를 비공개 금액에 인수하기로 합의했다. 애널리스트들은 이 회사의 가격 전망을 하향 조정했다.

코인베이스, 애플, 로빈후드 등 지난주 급락한 대형주 12종목 (3월 10일-3월 14일)

Genmab AS

WIIM

HROW

Harrow shares are trading higher on possible continued strength after the company issued Q4 and FY24 revenue guidance above estimates yesterday. HC Wainwright & Co. reiterated a Buy rating on the stock.

<p>NVIDIA today announced it is building a Boston-based research center to provide cutting-edge technologies to advance quantum computing.</p>
<p>The NVIDIA Accelerated Quantum Research Center, or NVAQC, will integrate leading quantum hardware with AI supercomputers, enabling what is known as accelerated quantum supercomputing. The NVAQC will help solve quantum computing's most challenging problems, ranging from qubit noise to transforming experimental quantum processors into practical devices.</p>
<p>Leading quantum computing innovators, including <a href="http://www.quantinuum.com/press-releases/quantinuum-selected-as-a-founding-collaborator-for-nvidia-accelerated-quantum-research-center">Quantinuum</a>, Quantum Machines and <a href="https://www.quera.com/press-releases/quera-joins-nvidia-accelerated-quantum-research-center-nvaqc-as-founding-member">QuEra Computing</a>, will tap into the NVAQC to drive advancements through collaborations with researchers from leading universities, such as the Harvard Quantum Initiative in Science and Engineering (HQI) and the Engineering Quantum Systems (EQuS) group at the Massachusetts Institute of Technology (MIT).</p>


NVDA

NVIDIA To Build Boston-Based Quantum Research Center To Advance Quantum Computing With AI Supercomputers

<p>Financial giants have made a conspicuous bullish move on Broadcom. Our analysis of options history for Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) revealed 153 unusual trades.</p>
<p>Delving into the details, we found 53% of traders were bullish, while 39% showed bearish tendencies. Out of all the trades we spotted, 80 were puts, with a value of $10,129,059, and 73 were calls, valued at $6,487,446.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $43.0 to $310.0 for Broadcom during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Broadcom's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Broadcom's significant trades, within a strike price range of $43.0 to $310.0, over the past month.</p>
<h3>Broadcom Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742326236_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$43.7</td>
<td>$42.0</td>
<td>$42.0</td>
<td>$195.00</td>
<td>$630.0K</td>
<td>73</td>
<td align="right">150</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$30.35</td>
<td>$30.3</td>
<td>$30.35</td>
<td>$192.00</td>
<td>$424.9K</td>
<td>492</td>
<td align="right">140</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$5.35</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$165.00</td>
<td>$157.5K</td>
<td>3.8K</td>
<td align="right">329</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$31.2</td>
<td>$30.9</td>
<td>$30.9</td>
<td>$200.00</td>
<td>$123.6K</td>
<td>391</td>
<td align="right">102</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$31.2</td>
<td>$30.85</td>
<td>$30.9</td>
<td>$200.00</td>
<td>$123.6K</td>
<td>391</td>
<td align="right">62</td>
</tr>
</tbody>
</table>
</p>
<h3>About Broadcom</h3>
<p>Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.</p>
<h3>Current Position of Broadcom</h3>
<ul>
<li>Trading volume stands at 16,619,669, with AVGO's price down by -2.93%, positioned at $188.81.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 85 days.</li>
</ul>
<h3>What Analysts Are Saying About Broadcom</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $266.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Benchmark downgraded its rating to Buy, setting a price target of $255.<br />
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $300.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Broadcom, which currently sits at a price target of $260.<br />
&#x2A; An analyst from Truist Securities persists with their Buy rating on Broadcom, maintaining a target price of $267.<br />
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Broadcom, which currently sits at a price target of $250. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Broadcom with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

AVGO

Looking At Broadcom's Recent Unusual Options Activity

<p>Financial giants have made a conspicuous bearish move on Coeur Mining. Our analysis of options history for Coeur Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) revealed 9 unusual trades.</p>
<p>Delving into the details, we found 33% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $78,740, and 7 were calls, valued at $775,250.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4.5 and $10.0 for Coeur Mining, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Coeur Mining's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Coeur Mining's significant trades, within a strike price range of $4.5 to $10.0, over the past month.</p>
<h3>Coeur Mining 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742326230_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CDE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.6</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$5.00</td>
<td>$257.5K</td>
<td>5.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CDE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.45</td>
<td>$1.3</td>
<td>$1.33</td>
<td>$7.50</td>
<td>$199.5K</td>
<td>14.7K</td>
<td>1.5K</td>
</tr>
<tr>
<td>CDE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$0.7</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$10.00</td>
<td>$150.2K</td>
<td>3.1K</td>
<td>2.5K</td>
</tr>
<tr>
<td>CDE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.0</td>
<td>$1.9</td>
<td>$2.0</td>
<td>$5.00</td>
<td>$50.0K</td>
<td>5.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CDE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.0</td>
<td>$0.9</td>
<td>$1.0</td>
<td>$7.50</td>
<td>$50.0K</td>
<td>3.7K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Coeur Mining</h3>
<p>Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.</p>
<p>After a thorough review of the options trading surrounding Coeur Mining, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Coeur Mining Standing Right Now?</h3>
<ul>
<li>With a volume of 16,059,910, the price of CDE is up 5.6% at $6.79. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 43 days.</li>
</ul>
<h3>Expert Opinions on Coeur Mining</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $8.08.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from BMO Capital has revised its rating downward to Outperform, adjusting the price target to $9.<br />
&#x2A; An analyst from Roth MKM persists with their Buy rating on Coeur Mining, maintaining a target price of $8.<br />
&#x2A; An analyst from TD Securities downgraded its action to Buy with a price target of $7. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Coeur Mining options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Looking At Coeur Mining's Recent Unusual Options Activity

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Lemonade</strong>.</p>
<p>Looking at options history for Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) we detected 13 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 30% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $180,065 and 10, calls, for a total amount of $560,364.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $48.0 for Lemonade, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Lemonade's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Lemonade's significant trades, within a strike price range of $20.0 to $48.0, over the past month.</p>
<h3>Lemonade Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742326225_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$16.6</td>
<td>$16.3</td>
<td>$16.45</td>
<td>$30.00</td>
<td>$202.3K</td>
<td align="right">414</td>
<td align="right">125</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$20.7</td>
<td>$20.5</td>
<td>$20.7</td>
<td>$45.00</td>
<td>$103.5K</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$5.0</td>
<td>$48.00</td>
<td>$61.0K</td>
<td align="right">6</td>
<td align="right">1</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.5</td>
<td>$8.3</td>
<td>$8.5</td>
<td>$32.00</td>
<td>$53.5K</td>
<td align="right">121</td>
<td align="right">64</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$20.0</td>
<td>$18.3</td>
<td>$18.5</td>
<td>$42.00</td>
<td>$46.2K</td>
<td align="right">103</td>
<td align="right">50</td>
</tr>
</tbody>
</table>
</p>
<h3>About Lemonade</h3>
<p>Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.</p>
<p>Following our analysis of the options activities associated with Lemonade, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Lemonade</h3>
<ul>
<li>With a trading volume of 1,272,405, the price of LMND is down by -5.0%, reaching $35.13.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 42 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Lemonade</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $47.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Lemonade, targeting a price of $34.<br />
&#x2A; An analyst from Citizens Capital Markets has revised its rating downward to Market Outperform, adjusting the price target to $60. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Lemonade, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


LMND

Lemonade Options Trading: A Deep Dive into Market Sentiment

<p><strong><a href="https://www.benzinga.com/personal-finance/25/03/44346708/charlie-munger-called-elon-musk-a-certified-genius-who-exaggerates-his-iq-but-warned-never-underestimate-the-man-who-overestimates-himself">Elon Musk</a></strong> recently claimed that Democrats are using entitlement programs — like Social Security and Medicaid — to attract undocumented immigrants, but experts have pushed back on this statement, saying there's no evidence to support it. Musk's comments have stirred political debate and raised questions about the future of <a href="https://www.benzinga.com/personal-finance/25/02/43592816/social-security-beneficiaries-have-every-reason-to-be-alarmed-by-musks-access-to-u-s-department-of-treasury-payment-system">Social Security</a> and other entitlement programs.</p>
<h2 class="wp-block-heading">Musk&#8217;s Claims About Entitlement Spending</h2>
<p>In a recent interview with <a href="https://x.com/atrupar/status/1899201171111264676">Fox Business</a>, Musk claimed that the U.S. government is losing up to $600 million to $700 billion per year to waste and fraud in entitlement programs. "That&#8217;s also the mechanism by which Democrats attract and retain illegal immigrants by essentially paying them to come here and then turning them into voters," he said.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv"><strong>The percentage may shock you</strong></a>.</strong></li>
<li><strong><a href="https://www.benzinga.com/money/arrived-private-credit-fund">Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom</a></strong></li>
</ul>
<p>Musk's claims align with statements made by President <strong>Donald Trump</strong>, who has also alleged widespread fraud in the Social Security system. Trump suggested during a speech to Congress that the Social Security Administration is making payments to deceased individuals, some listed as being up to 160 years old. However, there's no solid evidence to support these claims on the scale Musk and Trump have described.</p>
<h2 class="wp-block-heading">Experts Dispute Musk's Claims</h2>
<p>Experts have widely refuted Musk's allegations about entitlement fraud. <a href="https://oig.ssa.gov/news-releases/2024-08-19-ig-reports-nearly-72-billion-improperly-paid-recommended-improvements-go-unimplemented/">According</a> to the SSA Inspector General, approximately $72 billion in improper payments were made between 2015 and 2022 — less than 1% of the total Social Security benefits paid out during that period. While errors and fraud exist, they are not close to the levels Musk suggested.</p>
<p>Additionally, undocumented immigrants are not eligible to receive Social Security benefits. However, some pay into the system through payroll taxes using individual taxpayer Identification numbers or false Social Security numbers. This means they may contribute to Social Security but cannot collect benefits.</p>
<p><strong>Martin O'Malley</strong>, former SSA head under the Biden administration, warned that Musk and Trump's efforts to cut costs at the agency could lead to <a href="https://www.benzinga.com/personal-finance/25/03/44292349/if-i-were-a-beneficiary-id-be-setting-aside-some-money-right-now-former-ssa-commissioner-warns-that-payments-could-be-disrupted-soon">serious service disruptions</a>. He told <a href="https://www.cnbc.com/2025/03/01/doge-actions-may-cause-social-security-benefit-interruption-ex-agency-head.html">CNBC</a> that the SSA's staffing reductions and office closures could cause delays in processing claims and handling benefits.</p>
<p><strong>Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks"><strong>One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</strong></a></strong></p>
<h2 class="wp-block-heading">Political and Administrative Fallout</h2>
<p>Musk's comments have brought widespread debate from both sides of the aisle.&nbsp;</p>
<p>"There were howls of protest and denial from the GOP any time we pointed out that Republicans want to cut Social Security," former Secretary of Transportation <strong>Pete Buttigieg</strong> wrote <a href="https://x.com/PeteButtigieg/status/1899257453910368629">on X</a>. "Now the most powerful official in the White House goes on TV and calls it ‘the big one to eliminate.'"</p>
<p>Prior to Musk's comments, the Department of Government Efficiency — which Musk oversees — had already initiated cost-cutting measures at the SSA. The agency has announced plans to cut approximately 7,000 jobs and reduce its regional offices from 10 to four. Acting SSA Commissioner <strong>Leland Dudek</strong> has reportedly faced pressure from DOGE to eliminate "waste and fraud," but he has expressed concern that decisions are being made without sufficient understanding of SSA operations.</p>
<p>Despite Musk and Trump's aggressive push to reduce waste, they have not proposed cuts to Social Security benefits directly. Musk said <a href="https://x.com/elonmusk/status/1889002854708346938?s=46&amp;t=7MZjQjW2S78TQvoSIEUjXQ">on X</a> that his goal is to ensure Social Security "remains solvent and protects the social security checks of honest Americans!"</p>
<p><strong><em>See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it"><strong><em>Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</em></strong></a></em></strong></p>
<h2 class="wp-block-heading">The Reality of Social Security Fraud</h2>
<p>While Musk and Trump have suggested that millions of deceased Americans are receiving benefits, experts believe the issue stems from data entry errors rather than actual fraud. The <a href="https://www.benzinga.com/personal-finance/25/02/43957909/social-security-in-uncertain-times-what-the-resignation-of-michelle-king-and-musks-doge-data-push-could-mean-for-beneficiaries-2">SSA's computer systems</a>, which use outdated programming, default to a birth year of 1875 when birthdates are missing. This means some individuals are mistakenly listed as being over 150 years old. However, the SSA has a policy to terminate payments to beneficiaries over 115 years old to prevent fraud.</p>
<p>It's unclear whether Musk and DOGE will pursue additional cuts at the SSA or if their focus will remain on fraud investigations. Democratic lawmakers have voiced concerns that these efforts could undermine <a href="https://www.benzinga.com/25/03/44153127/will-social-securitys-restructuring-impact-your-monthly-benefits-heres-what-to-know">Social Security's ability to provide timely benefits</a>. Meanwhile, Musk's statements about entitlement fraud and undocumented immigrants continue to generate political tension, even as data suggests that widespread fraud remains rare.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"><strong> Here's how to turn it into lasting wealth</strong></a></strong></li>
<li><strong>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"><strong> </strong><strong>investors with $1M+ in DOGE revealed!</strong></a></strong></li>
</ul>


Personal Finance

Elon Musk Says Democrats Are Paying 'Illegal Immigrants' Through 'Entitlement Spending' — Experts Say He's Wrong

DMAC

DiaMedica Therapeutics shares are trading lower following a FY24 EPS miss.

RBOT

Vicarious Surgical shares are trading lower after Piper Sandler cut its price target on the stock from $10.5 to $8.5.

Health In Tech shares are trading lower after the company reported a year-over-year decrease in Q4 sales results.

USEA

United Maritime shares are trading lower. The company reported Q4 financial results.

<p><strong>Intuit's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NYSE">INTU</a>) short percent of float has risen 42.64% since its last report. The company recently reported that it has <strong>5.03 million shares sold short</strong>, which is 1.84% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.95 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Intuit Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742325325_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Intuit has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Intuit's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Intuit's peer group average for short interest as a percentage of float is 2.98%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

INTU

Is Intuit Gaining or Losing Market Support?

<p><strong>Willis Towers Watson's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NYSE">WTW</a>) short percent of float has fallen 6.8% since its last report. The company recently reported that it has <strong>1.06 million shares sold short</strong>, which is 1.37% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.77 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Willis Towers Watson Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742325320_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Willis Towers Watson has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Willis Towers Watson's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Willis Towers Watson's peer group average for short interest as a percentage of float is 2.51%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


What's Driving the Market Sentiment Around Willis Towers Watson?

<p><strong>Albemarle's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has risen 6.87% since its last report. The company recently reported that it has <strong>12.01 million shares sold short</strong>, which is 11.66% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.69 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742325315_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Albemarle has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 3.18%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


What Does the Market Think About Albemarle?

ALZN

Alzamend Neuro shares are trading higher after the company announced it will initiate a Phase II clinical trial of AL001 for major depressive disorder.

<p><strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has dropped 16% in the past month, leading some analysts to warn of <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44316555/bitcoin-ethereum-dogecoin-decline-xrp-clinging-on-as-traders-wargame-bear-market-scenarios">a macro downtrend</a>. </p>
<p><strong>What Happened:</strong> Ali Martinez, a widely followed crypto chart analyst, points to several key indicators that suggest Bitcoin may be entering a bear market phase.</p>
<p>In an X <a href="https://x.com/ali_charts/status/1902044982564757791">post</a> on Tuesday, Martinez said Bitcoin may be entering a macro downtrend, as multiple indicators signal a shift. </p>
<p>Large investors and miners have been actively taking profits, with miners realizing $27 million and whales cashing out over $260 million. </p>
<p>Capital inflows have also plummeted from $135 billion in December to just $4 billion. </p>
<p>Martinzez stated that key support lie in the $66,000–$69,000 range, where 750,000 investors bought 313,000 BTC.</p>
<p>Additional metrics, such as the UTXO Realized Price Distribution and Mayer Multiple, reinforce $66,000 and $69,354 as crucial levels. </p>
<p>Whether Bitcoin holds this support could determine if a full bear market unfolds.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44377385/bitcoin-remains-stuck-in-the-low-80000s-what-does-technical-analysis-say">Bitcoin Remains Stuck In The Low $80,000s: What Does Technical Analysis Say?</a></strong></p>
<p><strong>What's Next:</strong> For the upcoming price targets, Martinez suggests keeping an eye on historical trends. In the past 10-years, when Bitcoin plunged below the 50-day simple moving average, it eventually touched the 200-week SMA at $46,000.  </p>
<p>He added that with rising global liquidity, there is still hope. </p>
<p>This historically correlates with Bitcoin recoveries around mid-April. </p>
<p>Martinez predicts reclaiming $93,700 as support is likely to push Bitcoin prices towards the $111,000 mark based on price bands.  </p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44379524/what-will-happen-to-bitcoin-prices-if-donald-trump-and-vladimir-putin-agree-on-a-ceasefire-in-ukraine">What Will Happen To Bitcoin Prices If Donald Trump And Vladimir Putin Agree On A Ceasefire In Ukraine?</a></strong></li>
</ul>
<p><em>Image created using artificial intelligence with Midjourney.</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Drops 16% In A Month: Are Bear Market Signals Flashing?

WKSP

Worksport shares are trading higher. The company provided commentary for the business and an outlook for 2025.

Tech

NVIDIA Announces Isaac GR00T N1 Open Humanoid Robot Foundation Model

GOLD

SSRM

Shares of precious metals stocks are trading higher amid strength in gold and silver. Gold reached an all-time high.

PITA

Heramba Electric shares are trading lower after the company announced it received a Nasdaq notice regarding its minimum bid price requirements.

NBTX

Nanbotix shares are trading higher after the company announced funding obligations ammendents to a global licensing agreement which will strengthen its finances.

Press Releases

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

Genmab Publishes 2024 Annual Report

EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Comments

Genmab

뉴스

파트너 / 기고자

벤징가 글로벌